Response to Dahl et al.: Oral semaglutide improves postprandial glucose and lipid metabolism, and delays gastric emptying, in subjects with type 2 diabetes.
Diabetes, obesity & metabolism20216 citationsPMID: 34169640
Horowitz, Michael; Rayner, Christopher K; Marathe, Chinmay S; Wu, Tongzhi; Umapathysivam, Mahesh; Jones, Karen L
Response to Dahl et al.: Oral semaglutide improves postprandial glucose and lipid metabolism, and delays gastric emptying, in subjects with type 2 diabetes. | Pepdox